The research activities of the Center
for Head and Neck Cancers reflect the diverse
nature of the diseases treated, and the spectrum of
clinical and scientific interests of participating
professionals in medical oncology, surgical oncology,
and radiation oncology.
Selected Clinical Research Protocols
- Celecoxib in biomarker modulation of oral precancerous
lesions
- A phase II study of concomitant chemoradiation using
weekly carboplatinum/paclitaxel with or without daily
subcutaneous amifostine in locally advanced squamous
head and neck cancers
- A phase I trial of iressa plus celecoxib in metastatic
head and neck cancer
- A phase II study of ZD1839 in patients with advanced
thyroid cancer
Read
more on clinical research in head and neck cancers.
|
